Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium glycosides versus nicotinamide plus minocycline for bullous pemphigoid
ChiCTR-TRC-12003592Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Bullous Pemphigoid (BP) comparing Tripterygium glycosides group with Nicotinamide plus Minocycline group (2 arms). Primary endpoints: Number of new blisters or hemorrhagic blisters within 24 hours, Body surface area affected by erythema, blisters, and erosions and 10 more. Started Jan 2011; status: completed.
02
Drugs
tripterygium wilfordii polyglycosidesnicotinamideminocycline
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on ChiCTR-TRC-12003592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003592.